Cubist Systematic Strategies, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 101 filers reported holding TG THERAPEUTICS INC in Q1 2017. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.

Quarter-by-quarter ownership
Cubist Systematic Strategies, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,020,080
+61.9%
600,488
+381.0%
0.04%
+81.0%
Q2 2023$3,101,274
+49.2%
124,850
-9.7%
0.02%
+61.5%
Q1 2023$2,078,739
+410.2%
138,214
+301.3%
0.01%
+550.0%
Q4 2022$407,437
-59.7%
34,441
-79.8%
0.00%
-66.7%
Q3 2022$1,011,000
+756.8%
170,793
+514.5%
0.01%
+500.0%
Q2 2022$118,000
-91.4%
27,792
-80.7%
0.00%
-91.7%
Q1 2022$1,372,000
+225.9%
144,286
+551.2%
0.01%
+200.0%
Q4 2021$421,000
-1.4%
22,157
+101.4%
0.00%
-20.0%
Q2 2021$427,000
+33.4%
11,000
+65.9%
0.01%
+25.0%
Q1 2021$320,000
-73.7%
6,631
-71.7%
0.00%
-76.5%
Q4 2020$1,219,000
+584.8%
23,431
+29.5%
0.02%
+240.0%
Q1 2020$178,000
-93.5%
18,093
-92.7%
0.01%
-90.0%
Q4 2019$2,746,000
+5504.1%
247,364
+2762.3%
0.05%
+4900.0%
Q3 2019$49,000
+345.5%
8,642
+564.8%
0.00%
Q2 2019$11,000
-92.6%
1,300
-95.1%
0.00%
-100.0%
Q3 2018$149,000
-15.3%
26,598
+114.9%
0.01%
-20.0%
Q1 2018$176,000
-2.2%
12,376
-68.0%
0.01%
-28.6%
Q4 2016$180,000
+52.5%
38,622
+229.9%
0.01%
+133.3%
Q3 2015$118,000
+1585.7%
11,708
+2548.9%
0.01%
Q4 2014$7,0004420.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q1 2017
NameSharesValueWeighting ↓
Opaleye Management Inc. 1,890,000$15,800,4005.14%
Ghost Tree Capital, LLC 1,000,000$8,360,0002.75%
Soleus Capital Management, L.P. 2,884,382$24,113,4342.22%
M28 Capital Management LP 216,600$1,810,7762.08%
Paradigm Biocapital Advisors LP 3,619,015$30,254,9652.05%
683 Capital Management, LLC 1,350,000$11,286,0000.88%
Parkwood LLC 165,414$6,0810.66%
Spotlight Asset Group, Inc. 79,000$660,4400.60%
Pier Capital, LLC 392,709$3,283,0470.53%
Quantum Private Wealth, LLC 91,081$761,4380.36%
View complete list of TG THERAPEUTICS INC shareholders